Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes. (Q41090037)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 July 2015

Language	Label	Description	Also known as
English	Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes.	scientific article published on 17 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

Prabuddha S Pathinayake

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Rui Li

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mohammed Y E Chowdhury

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jae-Hoon Kim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tae-Hwan Kim

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Wan-Seo Koo

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Min-Eun Park

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ji-Eun Yoon

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jong-Bok Roh

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Seung-Pyo Hong

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Moon-Hee Sung

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chul-Joong Kim

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

17 July 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Veterinary Microbiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

179

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

250-263

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26210951%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Effects of lactobacilli on cytokine expression by chicken spleen and cecal tonsil cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Influenza vaccine: the challenge of antigenic drift.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The annual production cycle for influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Surface-displayed viral antigens on Salmonella carrier vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Recent progress in mucosal vaccine development: potential and limitations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Preparing for the next pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Key roles of adjuvants in modern vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal immunity and nasal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Influenza virus-like particles containing M2 induce broadly cross protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Influenza virus hemagglutinin--structural studies and their implications for the development of therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Assessment of Lactobacillus gasseri as a candidate oral vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Regulation of intestinal homeostasis and immunity with probiotic lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Emulsion-based adjuvants for influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2015.07.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41090037&oldid=2142288697"